6 results
diagnosis management druginduced erythematosus summary systemic activation comparison dil hematology hemophagocytic hlh macrophage syndrome table
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Systemic Lupus Erythematosus ... 40, F:M 9:1 • Clinical ... Manifestations: Malar ... life-threatening • Treatment ... Management #Summary #rheumatology
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... & NPSLE rare, Malar ... 40, F:M 9:1 • Clinical ... Manifestations: Malar ... #table #rheumatology
Hemophagocytic Lymphohistiocytosis (HLH) Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Hemophagocytic Lymphohistiocytosis ... accumulation of clinical ... Leishmaniosis, malaria ... Autoimmune diseases: SLE ... #summary #rheumatology
Macrophage Activation Syndrome (MAS) Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH) What? A subset of
disease • Systemic lupus ... SJIA], systemic lupus ... erythematosus [SLE ... Treatment: • Corticosteroids ... #Rheumatology
SLE (Systemic Lupus Erythematosus) Suspect: Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
SLE (Systemic Lupus ... ) Suspect: Clinical ... Non-autoimmune rheumatologic ... lymphoproliferative syndrome Clinical ... Photosensitivity • Malar
Drug Induced Lupus (DIL) • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
to 1:1 F:M • Clinical ... & NPSLE rare, Malar ... is rare in DIL, SCLE-DIL ... #DIL #rheumatology ... #diagnosis #treatment
No results found for "Plasmodium malaria rheumatology lupus speeds clinical peds sle treatment lymphohistiocytosis mas"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Plasmodium #malaria #rheumatology #lupus #speeds #clinical #peds #sle #treatment #lymphohistiocytosis #mas